Cyclosporine trough concentrations in predicting allograft rejection and renal toxicity up to 12 months after renal transplantation

David I. Min, Paul J. Perry, Hsiang Yin Chen, Lawrence G. Hunsicker

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Study Objective. To evaluate the utility of cyclosporine (CsA) trough concentrations as a monitoring tool for acute graft rejections and CsA nephrotoxicity. Design. Retrospective chart review. Setting. University- affiliated teaching hospital. Patients. One hundred thirty-seven adults who had undergone kidney transplantation. Measurements and Main Results. Clinical data extracted from the charts were CsA dosage, CsA trough levels (whole blood, HPLC method), biopsy findings to confirm acute rejections, and serum creatine to determine clearance by the Jelliffe method. Data were collected at up to 1 month, between i month and 3 months, and between 3 and 12 months after transplantation. For each time period, receiver's operating characteristics curves were generated to identify the optimum CsA concentration for avoiding acute rejection and CsA nephrotoxicity. At up to 1 month, the CsA therapeutic response threshold was 182 ng/ml (sensitivity 69%, specificity 84%, p0.1) and the toxicity threshold for CsA nephrotoxicity remained relatively static at 204 ng/ml (sensitivity 100%, specificity 14%, p

Original languageEnglish
Pages (from-to)282-287
Number of pages6
JournalPharmacotherapy
Volume18
Issue number2 I
Publication statusPublished - Mar 1998
Externally publishedYes

Fingerprint

Kidney Transplantation
Cyclosporine
Allografts
Kidney
Sensitivity and Specificity
Creatine
Graft Rejection
ROC Curve
Teaching Hospitals
Transplantation
High Pressure Liquid Chromatography
Biopsy
Serum
Therapeutics

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Cyclosporine trough concentrations in predicting allograft rejection and renal toxicity up to 12 months after renal transplantation. / Min, David I.; Perry, Paul J.; Chen, Hsiang Yin; Hunsicker, Lawrence G.

In: Pharmacotherapy, Vol. 18, No. 2 I, 03.1998, p. 282-287.

Research output: Contribution to journalArticle

@article{a4ad7586f81b4a589466e96de856a8b0,
title = "Cyclosporine trough concentrations in predicting allograft rejection and renal toxicity up to 12 months after renal transplantation",
abstract = "Study Objective. To evaluate the utility of cyclosporine (CsA) trough concentrations as a monitoring tool for acute graft rejections and CsA nephrotoxicity. Design. Retrospective chart review. Setting. University- affiliated teaching hospital. Patients. One hundred thirty-seven adults who had undergone kidney transplantation. Measurements and Main Results. Clinical data extracted from the charts were CsA dosage, CsA trough levels (whole blood, HPLC method), biopsy findings to confirm acute rejections, and serum creatine to determine clearance by the Jelliffe method. Data were collected at up to 1 month, between i month and 3 months, and between 3 and 12 months after transplantation. For each time period, receiver's operating characteristics curves were generated to identify the optimum CsA concentration for avoiding acute rejection and CsA nephrotoxicity. At up to 1 month, the CsA therapeutic response threshold was 182 ng/ml (sensitivity 69{\%}, specificity 84{\%}, p0.1) and the toxicity threshold for CsA nephrotoxicity remained relatively static at 204 ng/ml (sensitivity 100{\%}, specificity 14{\%}, p",
author = "Min, {David I.} and Perry, {Paul J.} and Chen, {Hsiang Yin} and Hunsicker, {Lawrence G.}",
year = "1998",
month = "3",
language = "English",
volume = "18",
pages = "282--287",
journal = "Pharmacotherapy",
issn = "0277-0008",
publisher = "Pharmacotherapy Publications Inc.",
number = "2 I",

}

TY - JOUR

T1 - Cyclosporine trough concentrations in predicting allograft rejection and renal toxicity up to 12 months after renal transplantation

AU - Min, David I.

AU - Perry, Paul J.

AU - Chen, Hsiang Yin

AU - Hunsicker, Lawrence G.

PY - 1998/3

Y1 - 1998/3

N2 - Study Objective. To evaluate the utility of cyclosporine (CsA) trough concentrations as a monitoring tool for acute graft rejections and CsA nephrotoxicity. Design. Retrospective chart review. Setting. University- affiliated teaching hospital. Patients. One hundred thirty-seven adults who had undergone kidney transplantation. Measurements and Main Results. Clinical data extracted from the charts were CsA dosage, CsA trough levels (whole blood, HPLC method), biopsy findings to confirm acute rejections, and serum creatine to determine clearance by the Jelliffe method. Data were collected at up to 1 month, between i month and 3 months, and between 3 and 12 months after transplantation. For each time period, receiver's operating characteristics curves were generated to identify the optimum CsA concentration for avoiding acute rejection and CsA nephrotoxicity. At up to 1 month, the CsA therapeutic response threshold was 182 ng/ml (sensitivity 69%, specificity 84%, p0.1) and the toxicity threshold for CsA nephrotoxicity remained relatively static at 204 ng/ml (sensitivity 100%, specificity 14%, p

AB - Study Objective. To evaluate the utility of cyclosporine (CsA) trough concentrations as a monitoring tool for acute graft rejections and CsA nephrotoxicity. Design. Retrospective chart review. Setting. University- affiliated teaching hospital. Patients. One hundred thirty-seven adults who had undergone kidney transplantation. Measurements and Main Results. Clinical data extracted from the charts were CsA dosage, CsA trough levels (whole blood, HPLC method), biopsy findings to confirm acute rejections, and serum creatine to determine clearance by the Jelliffe method. Data were collected at up to 1 month, between i month and 3 months, and between 3 and 12 months after transplantation. For each time period, receiver's operating characteristics curves were generated to identify the optimum CsA concentration for avoiding acute rejection and CsA nephrotoxicity. At up to 1 month, the CsA therapeutic response threshold was 182 ng/ml (sensitivity 69%, specificity 84%, p0.1) and the toxicity threshold for CsA nephrotoxicity remained relatively static at 204 ng/ml (sensitivity 100%, specificity 14%, p

UR - http://www.scopus.com/inward/record.url?scp=0031919768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031919768&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 282

EP - 287

JO - Pharmacotherapy

JF - Pharmacotherapy

SN - 0277-0008

IS - 2 I

ER -